|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
DE3642912A1
(de)
|
1986-12-16 |
1988-06-30 |
Leybold Ag |
Messeinrichtung fuer paramagnetische messgeraete mit einer messkammer
|
|
CA1341245C
(en)
|
1988-01-12 |
2001-06-05 |
F. Hoffmann-La Roche Ag |
Recombinant vaccinia virus mva
|
|
US5100587A
(en)
|
1989-11-13 |
1992-03-31 |
The United States Of America As Represented By The Department Of Energy |
Solid-state radioluminescent zeolite-containing composition and light sources
|
|
US5179993A
(en)
|
1991-03-26 |
1993-01-19 |
Hughes Aircraft Company |
Method of fabricating anisometric metal needles and birefringent suspension thereof in dielectric fluid
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
ATE336587T1
(de)
|
1994-06-10 |
2006-09-15 |
Genvec Inc |
Adenoviren-vektor systeme und zelllinien
|
|
US5851806A
(en)
|
1994-06-10 |
1998-12-22 |
Genvec, Inc. |
Complementary adenoviral systems and cell lines
|
|
US5965541A
(en)
|
1995-11-28 |
1999-10-12 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US5559099A
(en)
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
|
FR2727689A1
(fr)
|
1994-12-01 |
1996-06-07 |
Transgene Sa |
Nouveau procede de preparation d'un vecteur viral
|
|
US5837520A
(en)
|
1995-03-07 |
1998-11-17 |
Canji, Inc. |
Method of purification of viral vectors
|
|
IL160406A0
(en)
|
1995-06-15 |
2004-07-25 |
Crucell Holland Bv |
A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products
|
|
FR2737222B1
(fr)
|
1995-07-24 |
1997-10-17 |
Transgene Sa |
Nouveaux vecteurs viraux et lignee pour la therapie genique
|
|
US5837511A
(en)
|
1995-10-02 |
1998-11-17 |
Cornell Research Foundation, Inc. |
Non-group C adenoviral vectors
|
|
US5891690A
(en)
|
1996-04-26 |
1999-04-06 |
Massie; Bernard |
Adenovirus E1-complementing cell lines
|
|
IL127692A0
(en)
|
1996-07-01 |
1999-10-28 |
Rhone Poulenc Rorer Sa |
Method for producing recombinant adenovirus
|
|
AU5370598A
(en)
|
1996-12-13 |
1998-07-03 |
Schering Corporation |
Methods for purifying viruses
|
|
CA2283253A1
(en)
|
1997-03-04 |
1998-09-11 |
Baxter International Inc. |
Adenovirus e1-complementing cell lines
|
|
US6020191A
(en)
|
1997-04-14 |
2000-02-01 |
Genzyme Corporation |
Adenoviral vectors capable of facilitating increased persistence of transgene expression
|
|
US5972650A
(en)
|
1997-06-26 |
1999-10-26 |
Brigham And Women's Hospital |
Tetracycline repressor regulated mammalian cell transcription and viral replication switch
|
|
US5981225A
(en)
|
1998-04-16 |
1999-11-09 |
Baylor College Of Medicine |
Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same
|
|
US6113913A
(en)
|
1998-06-26 |
2000-09-05 |
Genvec, Inc. |
Recombinant adenovirus
|
|
US6440442B1
(en)
|
1998-06-29 |
2002-08-27 |
Hydromer, Inc. |
Hydrophilic polymer blends used for dry cow therapy
|
|
JP4802366B2
(ja)
|
1999-02-22 |
2011-10-26 |
トランスジェン・ソシエテ・アノニム |
精製ウイルス調製物の取得方法
|
|
ES2372823T3
(es)
|
1999-05-17 |
2012-01-26 |
Crucell Holland B.V. |
Adenovirus recombinante del serotipo ad11.
|
|
WO2003104467A1
(en)
|
2002-04-25 |
2003-12-18 |
Crucell Holland B.V. |
Means and methods for the production of adenovirus vectors
|
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
|
EP2363493B1
(en)
|
2003-02-20 |
2012-11-14 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Novel insertion sites in pox vectors
|
|
EP1528101A1
(en)
|
2003-11-03 |
2005-05-04 |
ProBioGen AG |
Immortalized avian cell lines for virus production
|
|
DE602005017743D1
(de)
|
2004-01-23 |
2009-12-31 |
Angeletti P Ist Richerche Bio |
Impfstoffträger für schimpansen-adenovirus
|
|
US7714119B2
(en)
*
|
2004-07-13 |
2010-05-11 |
Biosante Pharmaceuticals, Inc. |
AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
|
|
WO2007104792A2
(en)
|
2006-03-16 |
2007-09-20 |
Crucell Holland B.V. |
Recombinant adenoviruses based on serotype 26 and 48, and use thereof
|
|
WO2009046739A1
(en)
*
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating prostate cancer (pca)
|
|
AU2008312444B2
(en)
*
|
2007-10-18 |
2014-02-06 |
Bavarian Nordic A/S |
Use of MVA to treat prostate cancer
|
|
PL2391638T3
(pl)
|
2009-02-02 |
2018-11-30 |
Glaxosmithkline Biologicals Sa |
Sekwencje nukleotydowe i aminokwasowe małpiego adenowirusa, zawierające je wektory i ich zastosowania
|
|
WO2012177624A2
(en)
|
2011-06-21 |
2012-12-27 |
The Johns Hopkins University |
Focused radiation for augmenting immune-based therapies against neoplasms
|
|
CN102895659B
(zh)
*
|
2011-07-29 |
2014-10-29 |
复旦大学 |
一种防治老年痴呆症复合疫苗及其制备方法
|
|
DE102012108671A1
(de)
|
2012-09-17 |
2014-05-28 |
Paul Vahle Gmbh & Co. Kg |
Metall-Fremdkörper-Erkennungssystem für induktive Energieübertragungssysteme
|
|
RU2016109938A
(ru)
*
|
2013-08-21 |
2017-09-26 |
Куревак Аг |
Композиция и вакцина для лечения рака предстательной железы
|
|
WO2015061416A2
(en)
|
2013-10-23 |
2015-04-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
|
|
RS58080B1
(sr)
|
2014-11-04 |
2019-02-28 |
Janssen Vaccines & Prevention Bv |
Terapeutske vakcine protiv hpv16
|
|
JP6470872B2
(ja)
|
2015-08-20 |
2019-02-13 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． |
治療用ｈｐｖ１８ワクチン
|
|
JP7053491B2
(ja)
*
|
2016-05-02 |
2022-04-12 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
治療用ｈｐｖワクチン組み合わせ
|
|
EP3463450A4
(en)
*
|
2016-06-03 |
2020-07-29 |
Etubics Corporation |
COMPOSITIONS AND METHODS OF ANTI-TUMOR VACCINATION USING ANTIGENS ASSOCIATED WITH PROSTATE CANCER
|
|
RU2745500C2
(ru)
|
2016-06-20 |
2021-03-25 |
Янссен Вэксинс Энд Превеншн Б.В. |
Эффективный и сбалансированный двунаправленный промотор
|
|
JP2019526580A
(ja)
|
2016-09-02 |
2019-09-19 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． |
抗レトロウイルス処置を受けている対象においてヒト免疫不全ウイルス感染に対する免疫応答を誘発するための方法
|
|
KR102718353B1
(ko)
|
2016-10-17 |
2024-10-15 |
얀센 파마슈티칼즈, 인코포레이티드 |
재조합 바이러스 레플리콘 시스템 및 그의 용도
|
|
CA3045650A1
(en)
|
2016-12-05 |
2018-06-14 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for enhancing gene expression
|
|
US11034978B2
(en)
|
2017-02-09 |
2021-06-15 |
Janssen Vaccines & Prevention B.V. |
Potent and short promoter for expression of heterologous genes
|
|
ES2906441T3
(es)
|
2017-07-05 |
2022-04-18 |
Nouscom Ag |
Secuencias de ácidos nucleicos y de aminoácidos del adenovirus de los grandes simios no humanos, vectores que las contienen y usos de las mismas
|
|
KR102747530B1
(ko)
*
|
2017-11-03 |
2024-12-27 |
노우스콤 아게 |
백신 t 세포 인핸서
|